Calcium release deficiency syndrome: an emerging ryanodinopathy

Area of Science:

• Cardiology
• Molecular Biology
• Genetics

Background:

• Cardiac ryanodine receptor (RyR2) dysfunction is central to cardiac diseases like arrhythmias and heart failure.
• RyR2 mutations cause ryanodinopathies, expanding beyond gain-of-function (GOF) CPVT to include exon 3 deletion syndrome (E3DS) and calcium release deficiency syndrome (CRDS).

Purpose of the Study:

• To provide a comprehensive review of calcium release deficiency syndrome (CRDS), a distinct RyR2-related cardiac pathology.
• To elucidate the clinical manifestations, molecular mechanisms, diagnostic strategies, and therapeutic interventions for CRDS.

Main Methods:

• Literature review synthesizing current research on RyR2 function and dysfunction.
• Analysis of clinical data and molecular mechanisms associated with CRDS.
• Evaluation of diagnostic and therapeutic approaches for CRDS.

Main Results:

• CRDS arises from loss-of-function (LOF) RyR2 mutations, causing impaired calcium release from the sarcoplasmic reticulum.
• CRDS presents distinct clinical features and requires different management strategies compared to classical CPVT.
• Understanding CRDS pathophysiology is crucial for developing targeted therapies.

Conclusions:

• CRDS represents a significant, distinct clinical entity within RyR2-related cardiac disorders.
• Further research into CRDS mechanisms and therapeutic targets is essential.
• This review highlights the need for tailored diagnostic and clinical management approaches for CRDS patients.